Malignant hyperthermia (MH) is an autosomally inherited disorder characterized by an increase in heart rate, respiratory rate, body temperature, and muscle rigidity when the patient is exposed to potent volatile anesthetic gases and succinylcholine. The prevalence and incidence of MH are difficult to determine because patients display no characteristic signs until anesthetized with one of the triggering agents, and even then do not always develop the disorder. This article discusses the clinical presentation of MH, treatment using Dantrium® IV, and provides information on educational resources such as the Malignant Hyperthermia Association of the United States.

Leggi l’articolo completo in formato pdf: Current State of Malignant Hyperthermia And the Use of Dantrium IV as Treatment


Leave a Reply

You must be logged in to post a comment.